Nebulized amphotericin B prophylaxis for Aspergillus infection in lung transplantation: study of risk factors.
about
Inhaled anti-infective chemotherapy for respiratory tract infections: successes, challenges and the road aheadAspergillus infections in transplant recipients.Efficacy of nebulized liposomal amphotericin B in treatment of experimental pulmonary aspergillosisAspergillus colonization of the lung allograft is a risk factor for bronchiolitis obliterans syndromeAerosolized liposomal Amphotericin B: a potential prophylaxis of invasive pulmonary aspergillosis in immunocompromised patients.Liposomal amphotericin B: clinical experience and perspectives.Inhaled amphotericin B for prophylaxis against invasive Aspergillus infections.Increased mortality after pulmonary fungal infection within the first year after pediatric lung transplantation.The risk, prevention, and outcome of cytomegalovirus after pediatric lung transplantation.Fungal infections in pediatric lung transplant recipients: colonization and invasive disease.Prophylactic antifungal agents used after lung transplantation.Consensus summary of aerosolized antimicrobial agents: application of guideline criteria. Insights from the Society of Infectious Diseases Pharmacists.Lung transplantation: infection, inflammation, and the microbiome.Antifungal prophylaxis in solid organ transplant recipients.Anti-Aspergillus Prophylaxis in Lung Transplantation: A Systematic Review and Meta-analysis.Role of nebulized amphotericin B in the management of allergic bronchopulmonary aspergillosis in cystic fibrosis: Case report and review of literature.Is universal antifungal prophylaxis mandatory in adults after lung transplantation? A review and meta-analysis of observational studies.Variation in antifungal prophylaxis strategies in lung transplantation.Aerosolized Delivery of Antifungal Agents10 years of prophylaxis with nebulized liposomal amphotericin B and the changing epidemiology of Aspergillus spp. infection in lung transplantation.Aspergillosis in solid organ transplantation.Preemptive treatment with voriconazole in lung transplant recipients.Risk factors of invasive aspergillosis after heart transplantation: protective role of oral itraconazole prophylaxis.Aerosol deposition of lipid complex amphotericin-B (Abelcet) in lung transplant recipients.Safety of aerosolized liposomal versus deoxycholate amphotericin B formulations for prevention of invasive fungal infections following lung transplantation: a retrospective studyRisk Factors for Invasive Aspergillosis in Solid-Organ Transplant Recipients: A Case-Control Study
P2860
Q26822988-D4DE7B46-7511-4988-AE50-C8DC5D56DB01Q33719294-99AA7195-E716-49E0-9159-4100C060E95DQ33883785-D01F7F1C-FE93-4286-AAFB-1EEC975D9EC0Q34427034-F8C413A2-996E-4F10-9EB1-D6794B04DAA3Q34811537-9A61EE0B-6BA7-4182-B932-5BD32CCFB3C8Q36140647-1C28DEE8-B7AD-4D5F-8075-DA6AFA407CABQ36674772-FCF702B5-42E1-4CA6-AF76-05604A8A1F6FQ36748862-C74A0075-E97B-4E51-9AB3-717A15C8235CQ37304893-92F8B2A2-90E0-41E8-AD92-6BE4BDDCE7D1Q37435748-976FCD78-BE89-4C3F-893E-AC00077AD79CQ37697380-AD6E3A10-CE20-4745-ACC2-9103632B7257Q37760514-2BC7975E-166C-40D6-9EEE-31EECF6EEC74Q37832677-3DA7BCC3-6051-4ECD-A548-2E09DE9BFCFDQ37879201-EA70C0D6-6FB8-40E6-B599-7D3A15B3C4F5Q38156666-2D674875-F8AE-4134-BD1D-D7099ABCFB42Q38211509-B8F43B31-303C-4D50-8144-1AACFA769F74Q38960760-431ADC19-8289-4882-99EF-8AFA941E3663Q40268302-CA5CC0B4-F227-4F18-934A-7D6455C6BC37Q40522508-9D195584-4396-444D-8AAD-EB90E8D4486EQ41015559-E553D023-BC7A-4EBB-903F-7BA9017CD559Q42272291-E57A6E66-337A-42CC-8A76-C2995ECC2EC9Q44239236-E4A35CB8-1871-42C1-934A-EEBE080377C5Q44800864-5495871C-1D92-496F-9235-AFDFDB071BB5Q51116991-15859AE9-7E75-46E0-B443-953E81E126B8Q57053359-306E7CA4-7045-4A6B-9557-44A5DA82F983Q57569335-451423A3-0F48-49FB-B8CD-A05CFBE6B909
P2860
Nebulized amphotericin B prophylaxis for Aspergillus infection in lung transplantation: study of risk factors.
description
2001 nî lūn-bûn
@nan
2001年の論文
@ja
2001年学术文章
@wuu
2001年学术文章
@zh
2001年学术文章
@zh-cn
2001年学术文章
@zh-hans
2001年学术文章
@zh-my
2001年学术文章
@zh-sg
2001年學術文章
@yue
2001年學術文章
@zh-hant
name
Nebulized amphotericin B proph ...... tation: study of risk factors.
@en
Nebulized amphotericin B proph ...... tation: study of risk factors.
@nl
type
label
Nebulized amphotericin B proph ...... tation: study of risk factors.
@en
Nebulized amphotericin B proph ...... tation: study of risk factors.
@nl
prefLabel
Nebulized amphotericin B proph ...... tation: study of risk factors.
@en
Nebulized amphotericin B proph ...... tation: study of risk factors.
@nl
P2093
P1476
Nebulized amphotericin B proph ...... tation: study of risk factors.
@en
P2093
P304
P356
10.1016/S1053-2498(01)00364-3
P577
2001-12-01T00:00:00Z